Beyondspring Inc. income statement
In fiscal 2025, Beyondspring Inc. reported revenue of $0 and net income of −$1.0m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Research and development | 2 | 6 | 10 | 89 | 52 | 31 | 42 | 37 | 26 | 7 | 3 | 4 | 5 |
| Selling, general and administrative | — | — | 2 | 9 | 6 | 9 | 23 | 31 | 13 | 8 | 6 | 5 | 4 |
| General and administrative | 0 | 1 | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −2 | −7 | −12 | −98 | −58 | −40 | −64 | −66 | −37 | −15 | −9 | −9 | −8 |
| Interest expense | 1 | 1 | — | — | — | 0 | 0 | 0 | 0 | — | — | — | — |
| Income before tax | −3 | −8 | −13 | −96 | −57 | −40 | −64 | −65 | −36 | −14 | −9 | −9 | −8 |
| Income tax | — | — | — | — | — | 0 | 0 | 4 | 0 | −0 | 0 | 0 | 0 |
| Net income | −3 | −8 | −12 | −92 | −55 | −38 | −61 | −64 | −33 | −21 | −11 | −1 | −7 |
| Diluted EPS | −$0.22 | −$0.53 | −$0.75 | −$4.40 | −$2.42 | −$1.55 | −$2.03 | −$1.64 | — | — | — | — | — |
| Diluted shares (average) | 14m | 15m | 16m | 21m | 23m | 25m | 30m | 39m | 39m | — | — | — | — |
| EBITDA | −2 | −7 | −12 | −98 | −57 | −40 | −64 | −66 | −37 | −15 | −8 | −9 | −8 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | 622 | 472 | 874 | 1,002 | 1,039 | 1,473 | 1,076 | 973 |
| Selling, general and administrative | 1,736 | 1,228 | 1,736 | 947 | 751 | 1,123 | 1,156 | 758 |
| Operating income | −2,358 | −1,700 | −2,610 | −1,949 | −1,790 | −2,596 | −2,232 | −1,731 |
| Income before tax | −2,215 | −1,823 | −2,564 | −1,856 | −1,717 | −2,488 | −2,159 | −1,650 |
| Income tax | 0 | 96 | 20 | 22 | 26 | 22 | 192 | 100 |
| Net income | −2,132 | −1,729 | 4,477 | −1,806 | −1,540 | −2,137 | −2,159 | −849 |
| Diluted EPS | — | — | — | −$0.10 | $0.16 | — | — | — |
| EBITDA | −2,275 | −1,680 | −2,530 | −1,867 | −1,709 | −2,752 | −2,213 | −1,712 |
More: Biotechnology stocks compared, Health Care sector, rankings of US companies